Literature DB >> 8437106

Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.

M J Marks1, D A Farnham, S R Grady, A C Collins.   

Abstract

The ability of nicotinic agonists to activate ion channels resulting in Na+ and K+ fluxes has been used to develop a functional assay by using mouse brain synaptosomes. Synaptosomes prepared using Percoll gradients were enriched in binding sites for [3H]nicotine and were capable of accumulating the K+ analog, 86Rb+. The efflux of 86Rb+ from the synaptosomes was subsequently monitored using continuous superfusion at 21 degrees C. Ion flux was stimulated in a concentration-dependent manner by several nicotinic agonists, including L-nicotine, acetylcholine, N-methylcarbamylcholine and dimethylphenylpiperazinium. The process was stereoselective: L-nicotine was 30-fold more potent than D-nicotine. Cytisine stimulated ion flux at low concentrations, but this drug was less efficacious than most other agonists tested. Anabasine was also less efficacious than the other agonists. The EC50 values for agonist-stimulated efflux correlated closely to the IC50 values for inhibition of [3H]nicotine binding, but concentrations required to inhibit binding were lower than those required to stimulate ion flux. Nicotine-induced 86Rb+ efflux was blocked by several nicotinic antagonists including mecamylamine, D-tubocurarine, hexamethonium and decamethonium. Mecamylamine was approximately 50 times as potent as hexamethonium. Neither alpha-bungarotoxin nor atropine were effective antagonists and neuronal-bungarotoxin was a relatively ineffective inhibitor. The amount of nicotine-induced efflux varied among brain regions with midbrain (thalamus and mesencephalon) having the largest response and cerebellum the smallest. The magnitude of the ion flux correlated closely with the amount of [3H] nicotine binding in each brain region. The results indicate that a nicotinic-receptor-mediated ion flux can be measured in brain tissue and that the ion flux may serve as a useful functional assay for nicotinic receptors in the central nervous system. Furthermore, it is postulated that the nicotinic-agonist stimulated ion flux may be mediated by receptors measured by high affinity [3H]nicotine binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437106

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors.

Authors:  Sharon R Grady; Ryan M Drenan; Scott R Breining; Daniel Yohannes; Charles R Wageman; Nikolai B Fedorov; Sheri McKinney; Paul Whiteaker; Merouane Bencherif; Henry A Lester; Michael J Marks
Journal:  Neuropharmacology       Date:  2010-01-28       Impact factor: 5.250

Review 2.  Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors.

Authors:  Bruce E McKay; Andon N Placzek; John A Dani
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

3.  Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors.

Authors:  Gregory P Hussmann; Robert P Yasuda; Yingxian Xiao; Barry B Wolfe; Kenneth J Kellar
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

4.  Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance.

Authors:  Susan E Robinson; John R James; Laura N Lapp; Robert E Vann; Daniel F Gross; Scott D Philibin; John A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  2005-07-12       Impact factor: 4.530

5.  Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.

Authors:  G I Wilkie; P Hutson; J P Sullivan; S Wonnacott
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

6.  Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation.

Authors:  P Scholze; A Orr-Urtreger; J-P Changeux; J M McIntosh; S Huck
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

7.  Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.

Authors:  P B Clarke; M Reuben
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

8.  Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.

Authors:  H el-Bizri; P B Clarke
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

9.  5-fluoronicotine, noranhydroecgonine, and pyridyl-methylpyrrolidine release acetylcholine and biogenic amines in rat cortex in vivo.

Authors:  K L Summers; P Lippiello; S Verhulst; E Giacobini
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

10.  The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.

Authors:  P B Clarke; I Chaudieu; H el-Bizri; P Boksa; M Quik; B A Esplin; R Capek
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.